Migraine Treatment: CGRP Drugs, Botox, and What to Check in Your Coverage

Migraine that keeps recurring isn't just a "bad headache" — it's a neurological condition that can disrupt daily function, and in recent years especially effective new treatments for chronic migraine have entered the market: preventive drugs from the CGRP class, dedicated Botox injections, and ongoing neurological care alongside them. The question most people actually have isn't "what treatments exist" but "what's covered for me, and under what conditions" — and that's exactly what this article tries to answer.

Preventive CGRP drugs — what to check

Anti-CGRP drugs are a relatively new class of biologic medications designed to prevent migraine attacks, as opposed to drugs meant to relieve an attack that has already started. Some drugs in this class are included in Israel's national health basket, but inclusion is conditioned on defined clinical criteria — for example, a minimum number of migraine days per month, and documentation that other preventive treatments (such as blood-pressure medications or anti-epileptic drugs also used for migraine prevention) haven't helped enough. Meeting these clinical criteria is what determines your individual eligibility; budget estimates of the expected patient population are used by the fund for general budget planning only, and are not grounds to deny coverage to a patient who meets the clinical criteria.

Because the health basket is updated every year — with new drugs entering and leaving it — the most accurate information is always what currently appears on the Ministry of Health site and in your fund's procedures, not what you heard in the past.

Botox for chronic migraine — when it comes into play

Botox injections for migraine prevention are a recognized and approved treatment, but they are intended mainly for chronic migraine — a medical definition that generally refers to someone suffering from 15 or more headache days a month, with at least some meeting migraine criteria. The treatment is given at fixed intervals (usually every few months) and initially requires approval based on medical documentation showing that prior drug treatments have failed.

Funding for migraine Botox, whether through the health basket or supplemental insurance, is usually subject to a committee or pre-approval from the fund, so it's important to check in advance what the process is and which documents are required, rather than showing up at the clinic without approval in hand.

Neurologist visits and diagnostic tests

Diagnosing migraine and monitoring treatment usually requires repeat visits to a neurologist, and sometimes also imaging tests (like an MRI) to rule out other causes of the headache. Neurologist visits through the health fund require a referral and a copay per the fund's price list, while a private visit to a neurologist can be faster but significantly more expensive — which is where supplemental or private insurance comes in, sometimes covering part of the private visit's cost or shortening the wait for a fund appointment. It's also worth checking general coverage for imaging tests if imaging is needed.

What private insurance and shaban plans can add

Beyond what's included in the health basket, private policies and shaban plans may cover drugs not in the basket ("out-of-basket drugs"), innovative drug treatments not yet added to the basket, or a share of the cost of private neurologist visits. This coverage is usually subject to a copay, an annual cap, and sometimes pre-approval or medical documentation of failed prior treatments similar to the basket's terms. Anyone paying a lot out of pocket for migraine drugs should check the relevant clause in their policy and the option of using the relevant out-of-basket drug coverage.

Criteria, approval committees, and appealing a denial

Because advanced migraine treatments are relatively expensive, most funding bodies — a health fund, insurer, or shaban plan — require clear criteria to be met before approval: documentation of attack frequency, a list of prior treatments tried and failed, and sometimes an up-to-date neurology opinion. If a request is denied, you can usually appeal by attaching additional documents, and if the appeal is also denied — turn to an exceptions committee. It's worth keeping copies of every document submitted and tracking the deadlines.

What to check before starting treatment

• Whether the requested drug or treatment is included in the health basket, and what clinical criteria condition eligibility.
• Whether pre-approval or a specialist committee is required, and exactly which documents the request needs.
• Whether your private policy or shaban plan covers out-of-basket drugs or private neurologist visits, and under what terms.
• What the copay and annual cap are for the relevant coverage.
• What the appeal path is if a request is denied, and the deadlines for filing it.

How Ravit can help

Instead of trying to figure out on your own whether a CGRP drug or Botox treatment is covered for you, you can send Ravit your policy documents or shaban plan on WhatsApp and ask in plain language what's needed to get approval — with a reference to the relevant policy clause. And when the information isn't certain, Ravit says so plainly instead of guessing.

The information in this article is general only and does not constitute medical, insurance, legal, or pension advice, and is not a substitute for reading your policy terms or consulting a licensed professional. Coverage, amounts, and conditions vary between policies and change over time — always verify against your own specific policy and an authorized professional.